The metabolism of neuronal iron and its pathogenic role in neurological disease review

Annals of the New York Academy of Sciences

Volumn 1012, Issue , 2004, Pages 14-26

  Moos, Torben ^a,c   Morgan, Evan H ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Axonal transport; Brain; dcytB; Divalent metal transporter 1 (DMT1); Ferritin; Ferroportin; Hemorrhage; Hephaestin; Iron; Iron deficiency; Ischemia; Parkinson's disease; Transferrin receptor

Indexed keywords

CARRIER PROTEIN; ENZYME; FERRIC ION; FERRITIN; FERROUS ION; HEPHAESTIN; IRON; IRON REDUCTASE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; NEUROMELANIN; OXIDOREDUCTASE; TRANSFERRIN; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; BRAIN; BRAIN HEMORRHAGE; BRAIN INJURY; BRAIN ISCHEMIA; CAPILLARY ENDOTHELIUM; CELL DAMAGE; CYTOSOL; DEGENERATIVE DISEASE; DETOXIFICATION; DOPAMINERGIC NERVE CELL; DRUG TARGETING; ENDOSOME; ENZYME INHIBITION; EXTRACELLULAR FLUID; HUMAN; HUNTINGTON CHOREA; INTERNALIZATION; IRON DEFICIENCY; IRON METABOLISM; IRON STORAGE; IRON TRANSPORT; NERVE CELL; NEUROLOGIC DISEASE; NONHUMAN; OXIDATION REDUCTION REACTION; PARKINSON DISEASE; PATHOGENESIS; PROTEIN EXPRESSION; RECEPTOR BLOCKING; REDUCTION; REVIEW; SUBSTANTIA NIGRA;

EID: 1842504357     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1306.002     Document Type: Review

References (71)

1. MORGAN, E.H. 1996. Iron metabolism and transport. In Hepatology: A Textbook of Liver Disease. Third edition, pp. 526-554. Saunders. Philadelphia.
2. WALKER, B.L., J.W.C. TIONG & W.A. JEFFERIES. 2001. Iron metabolism in mammalian cells. Int. Rev. Cytol. 211: 241-278.
3. WRIGGELSWORTH, J.M. & H. BAUM. 1988. Iron-dependent enzymes in the brain. In Brain Iron: Neurochemical and Behavioral Aspects, pp. 25-66. Taylor & Francis. Philadelphia/London.
4. LASKEY, J., I. WEBB, H.M. SCHULMAN et al. 1988. Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis. Exp. Cell Res. 176: 87-95.
5. LEVY, J.E., O. JIN, Y. FUJIWARA et al. 1999. Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nat. Genet. 21: 396-399.
6. MOOS, T. & E.H. MORGAN. 2002. A morphological study of the developmentally regulated transport of iron into the brain. Dev. Neurosci. 24: 99-105.
7. MOOS, T., P.S. OATES & E.H. MORGAN. 1998. Expression of the neuronal transferrin receptor is age dependent and susceptible to iron deficiency. J. Comp. Neurol. 398: 420-430.
8. TAYLOR, E.M., A. CROWE & E.H. MORGAN. 1991. Transferrin and iron uptake by the brain: effects of altered iron status. J. Neurochem. 57: 1584-1592.
9. MORGAN, E.H. & T. MOOS. 2002. Mechanism and developmental changes in iron transport across the blood-brain barrier. Dev. Neurosci. 24: 106-113.
10. ALLEN, R.P., P.B. BARKER, F. WEHRL et al. 2001. MRI measurement of brain iron in patients with restless legs syndrome. Neurology 56: 263-265.
11. DE DEUNGRIA, M., R. RAO, J.D. WOBKEN et al. 2000. Perinatal iron deficiency decreases cytochrome c oxidase (CytOx) activity in selected regions of neonatal rat brain. Pediatr. Res. 48: 169-176.
12. YOUDIM, M.B. & D. BEN-SHACHAR. 1987. Minimal brain damage induced by early iron deficiency: modified dopaminergic neurotransmission. Isr. J. Med. Sci. 23: 19-25.
13. BEARD, J., K.M. ERIKSON & B.C. JONES. 2003. Neonatal iron deficiency results in irreversible changes in dopamine function in rats. J. Nutr. 133: 1174-1179.
14. CURTIS, A.R., C. FEY, C.M. MORRIS et al. 2001. Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nat. Genet 28: 350-354.
15. ZHOU, B., S.K. WESTAWAY, B. LEVINSON et al. 2001. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat. Genet. 28: 345-349.
16. PATEL, B.N., R.J. DUNN, S.Y. JEONG et al. Ceruloplasmin regulates iron levels in the CNS and prevents free radical injury. J. Neurosci. 22: 6578-6586.
17. LAVAUTE, T., S. SMITH, S. COOPERMAN et al. 2001. Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nat. Genet. 27: 209-214.
18. NAPPI, A.J. & E. VASS. 2000. Iron, metalloenzymes, and cytotoxic reactions. Cell. Mol. Biol. 46: 637-647.
19. JELLINGER, K.A. 1999. The role of iron in neurodegeneration: prospects for pharmacotherapy of Parkinson's disease. Drugs Aging 14: 115-140.
20. FOCHT, S.J., B.S. SNYDER, J.L. BEARD et al. 1997. Regional distribution of iron, transferrin, ferritin, and oxidatively-modified proteins in young and aged Fischer 344 rat brains. Neuroscience 79: 255-261.
21. BARTZOKIS, G., M. BECKSON, D.B. HANCE et al. 1997. MR1 evaluation of age-related increase of brain iron in young adult and older normal males. Magn. Reson. Imag. 15: 29-35.
22. BARTZOKIS, G., D. SULTZER, J. MINTZ et al. 1994. In vivo evaluation of brain iron in Alzheimer's disease and normal subjects using MRI. Biol. Psychiatry 35: 480-487.
23. BARTZOKIS, G., J. CUMMINGS, S. PERLMAN et al. 1999. Increased basal ganglia iron levels in Huntington disease. Arch. Neurol. 56: 569-574.
24. DEXTER, D.T., F.R. WELLS, A.J. LEES et al. 1989. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease. J. Neurochem. 52: 1830-1836.
25. MOOS, T. 1996. Immunohistochemical localization of intraneuronal transferrin receptor immunoreactivity in the adult mouse central nervous system. J. Comp. Neurol. 375: 675-692.
26. GUNSHIN, H., B. MACKENZIE, U.V. BERGER et al. 1997. Cloning and characterization of a mammalian proton-coupled metal-ion transporter. Nature 388: 482-488.
27. MOOS, T., D. TRINOER & E.H. MORGAN. 2000. Cellular distribution of ferric iron, ferritin, transferrin, and divalent metal transporter 1 (DMT1) in substantia nigra and basal ganglia of normal and beta2-microglobulin deficient mouse brain. Cell. Mol. Biol. 46: 549-561.
28. BUROO, J.R., S.L. MENZIES, I.A. SIMPSON et al. Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66: 1198-1207.
29. MOOS, T. & E.H. MORGAN. 2003. How does mutation of divalent metal transporter (DMT1) explain the impaired transport of iron into the Belgrade rat brain? J. Neurochem. 88: 233-245.
30. PONTING, C.P. 2001 Domain homologues of dopamine beta-hydroxylase and ferric reductase: roles for iron metabolism in neurodegenerative disorders? Hum. Mol. Genet. 10: 1853-1858.
31. MCKIE, A.T, D. BARROW, G.O. LATUNDE-DADA et al. 2001. An iron-regulated ferric reductase associated with the absorption of dietary iron. Science 291: 1755-1759.
32. MOOS, T. & E.H. MORGAN. 1998. Evidence for low molecular weight, non-transferrin-bound iron in rat brain and cerebrospinal fluid. J. Neurosci. Res. 54: 486-494.
33. KNUTSON, M.D., J.E. LEVY, N.C. ANDREWS et al. 2001. Expression of stimulator of Fe transport is not enhanced in Hfe knockout mice. J. Nutr. 131: 1459-1464.
34. GUTIERREZ, J.A., J. YU, S. RIVERA et al. 1997. Functional expression cloning and characterization of SFT, a stimulator of Fe transport. J. Cell Biol. 139: 895-905.
35. MORGAN, E.H. 1979. Studies on the mechanism of iron release from transferrin. Biochim. Biophys. Acta 580: 312-326.
36. HANSEN, T.M., H. NIELSEN, N. BERNTH et al. 1999. Expression of ferritin protein and subunit mRNAs in normal and iron deficient rat brain. Mol. Brain Res. 65: 186-197.
37. MOOS, T., P.S. OATES & E.H. MORGAN. 1999. Iron-independent neuronal expression of transferrin receptor mRNA in the rat. Brain Res. Mol. Brain Res. 72: 231-234.
38. MORRIS, C.M., A.B. KEITH, J.A. EDWARDSON et al. 1992. Uptake and distribution of iron and transferrin in the adult rat brain. J. Neurochem. 59: 300-306.
39. MOOS, T. & E.H. MORGAN. 1998. Kinetics and distribution of [59Fe-125I]transferrin injected into the ventricular system of the rat. Brain Res. 790: 115-128.
40. ABBOUD, S. & D.J. HAILE. 2000. A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J. Biol. Chem. 275: 19906-19912.
41. DONOVAN, A., A. BROWNLIE, Y. ZHOU et al. 2000. Positional cloning of zebrafish ferroportin 1 identifies a conserved vertebrate iron exporter. Nature 403: 776-781.
42. MCKIE, A., P. MARCIANI, A. ROLFS et al. 2000. A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol. Cell 5: 299-309.
43. VULPE, C.D., Y.M. KUO et al. 1999. Hephaestin, a ceruloplasmin homologue implicated in intestinal iron transport, is defective in the sla mouse. Nat. Genet. 21: 195-199.
44. ANDERSON, G.J., D.M. FRAZER et al. 2002. The ceruloplasmin homolog hephaestin and the control of intestinal iron absorption. Blood Cells Mol. Dis. 29: 367-375.
45. PATEL, B.N. & S.A. DAVID. 1997. A novel glycosylphosphatidylinositol- anchored form of ceruloplasmin is expressed by mammalian astrocytes. J. Biol. Chem. 272: 20185-20190.
46. QIAN, Z.M., Y.K. TSOI, Y. KE et al. 2001. Ceruloplasmin promotes iron uptake rather than release in BT325 cells. Exp. Brain Res. 140: 369-374.
47. DWORK, A.J., G. LAWLER, P.A. ZYBERT et al. 1990. An autoradiographic study of the uptake and distribution of iron by the brain of the young rat. Brain Res. 518: 31-39.
48. WAGNER, K.R., F.R. SHARP, T.D. ARDIZZONE et al. 2003. Heme and iron metabolism: role in cerebral hemorrhage. J. Cereb. Blood Flow Metab. 23: 629-652.
49. TURNER, C.P., M. BERGERON et al. 1998. Heme oxygenase-1 is induced in glia throughout brain by subarachnoid hemoglobin. J. Cereb. Blood Flow Metab. 18: 257-273.
50. HUANG, P.P., G. XI, R.F. KEEP et al. 2002. Brain edema after experimental intracerebral hemorrhage: role of hemoglobin degradation products. J. Neurosurg. 96: 287-293.
51. CHAKRABARTY, A., M.R. EMERSON & S.M. LEVINE. 2003. Heme oxygenase-1 in SJL mice with experimental allergic encephalomyelitis. Mult. Scler. 9: 372-381.
52. VERMA, A., D.J. HIRSCH, C.E. GLATT et al. 1993. Carbon monoxide: a putative neural messenger. Science 259: 381-384.
53. CHI, S.I., C.K. WANG, J.J. CHEN et al. 2000. Differential regulation of H-and L-ferritin messenger RNA subunits, ferritin protein, and iron following focal cerebral ischemia-reperfusion. Neuroscience 100: 475-484.
54. KONDO, Y., N. OGAWA, M. ASANUMA et al. 1995. Regional differences in late-onset iron deposition, ferritin, transferrin, astrocyte proliferation, and microglial activation after transient forebrain ischemia in rat brain. J. Cereb. Blood Flow Metab. 15: 216-226.
55. OMORI, N., K. MARUYAMA, G. JIN et al. 2003. Targeting of post-ischemic cerebral endothelium in rat by liposomes bearing polyethylene glycol-coupled transferrin. Neurol. Res. 25: 275-279.
56. LOK, C.N. & P. PONKA. 1999. Identification of a hypoxia response element in the transferrin receptor gene. J. Biol. Chem. 274: 24147-24152.
57. BERG, D., M. GERLACH, M.B. YOUDIM et al. 2001. Brain iron pathways and their relevance to Parkinson's disease. J. Neurochem. 79: 225-236.
58. BENKOVIC, S.A. & J.R. CONNOR. 1993. Ferritin, transferrin, and iron in selected regions of the adult and aged rat brain. J. Comp. Neurol. 338: 97-113.
59. CONNOR, J.R., B.S. SNYDER, P. AROSIO et al. 1995. A quantitative analysis of isoferritins in select regions of aged, parkinsonian, and Alzheimer's diseased brains. J. Neurochem. 65: 717-724.
60. LEIBOLD, E.A., L.C. GAHRING & S.W. ROGERS. 2001. Immunolocalization of iron regulatory protein expression in the murine central nervous system. Histochem. Cell Biol. 115: 195-203.
61. FAUCHEUX, B.A., M.E. MARTIN, C. BEAUMONT et al. 2003. Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease. J. Neurochem. 86: 1142-1148.
62. MIRZA, B., H. HADBERG, P. THOMSEN et al. 2000. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease. Neuroscience 95: 425-432.
63. ZECCA, L., D. TAMPELLINI, A. GATTI et al. 2002. The neuromelanin of human substantia nigra and its interaction with metals. J. Neural Transm. 109: 663-672.
64. FAUCHEUX, B.A., M.E. MARTIN, C. BEAUMONT et al. 2002. Lack of up-regulation of ferritin is associated with sustained iron regulatory protein-1 binding activity in the substantia nigra of patients with Parkinson's disease. J. Neurochem. 83: 320-330.
65. TANAKA, J., K. TOKU, B. ZHANG et al. 1999. Astrocytes prevent neuronal death induced by reactive oxygen and nitrogen species. Glia 28: 85-96.
66. HAYFLICK, S.J., S.K. WESTAWAY, B. LEVINSON et al. 2003. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N. Engl. J. Med. 348: 33-40.
67. GRABILL, C., A.C. SILVA, S.S. SMITH et al. 2003. MRI detection of ferritin iron overload and associated neuronal pathology in iron regulatory protein-2 knockout mice. Brain Res. 971: 95-106.
68. OLOYEDE, O.B., A.T. FOLAYAN & A.A. ODUTUGA. 1992. Effects of low-iron status and deficiency of essential fatty acids on some biochemical constituents of rat brain. Biochem. Int. 27: 913-922.
69. YU, G.S., T.M. STEINKIRCHNER, G.A. RAO et al. 1986. Effect of prenatal iron deficiency on myelination in rat pups. Am. J. Pathol. 125: 620-624.
70. GOTO, K., H. MOCHIZUKI, H. IMAI et al. 1996. An immuno-histochemical study of ferritin in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) -induced hemiparkinsonian monkeys. Brain Res. 724: 125-128.
71. HE, Y., P.S. THONG & T. LEE. 2003. Dopaminergic cell death precedes iron elevation in MPTP-injected monkeys. Free Radical Biol. Med. 35: 540-547.